Global Subcutaneous Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Subcutaneous Immunotherapy Market Overview

• 1.1 Product Overview and Scope of Subcutaneous Immunotherapy
• 1.2 Classification of Subcutaneous Immunotherapy by Types
  • 1.2.1 Global Subcutaneous Immunotherapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Subcutaneous Immunotherapy Revenue Market Share by Types in 2018
  • 1.2.3 Asthma
  • 1.2.4 Allergic Rhinitis
  • 1.2.5 Venom Allergy
  • 1.2.6 Food Allergy
• 1.3 Global Subcutaneous Immunotherapy Market by Application
  • 1.3.1 Global Subcutaneous Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Online Pharmacies
  • 1.3.4 Retail Pharmacies
• 1.4 Global Subcutaneous Immunotherapy Market by Regions
  • 1.4.1 Global Subcutaneous Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Subcutaneous Immunotherapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Subcutaneous Immunotherapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Subcutaneous Immunotherapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Subcutaneous Immunotherapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Subcutaneous Immunotherapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of Subcutaneous Immunotherapy (2014-2024)

2 Manufacturers Profiles

• 2.1 Anergis
  • 2.1.1 Business Overview
  • 2.1.2 Subcutaneous Immunotherapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Anergis Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 HAL Allergy Group
  • 2.2.1 Business Overview
  • 2.2.2 Subcutaneous Immunotherapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 HAL Allergy Group Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Merck
  • 2.3.1 Business Overview
  • 2.3.2 Subcutaneous Immunotherapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Merck Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Allergy Therapeutics
  • 2.4.1 Business Overview
  • 2.4.2 Subcutaneous Immunotherapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Allergy Therapeutics Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 ALK-Abello
  • 2.5.1 Business Overview
  • 2.5.2 Subcutaneous Immunotherapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 ALK-Abello Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Stallergenes Greer
  • 2.6.1 Business Overview
  • 2.6.2 Subcutaneous Immunotherapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Stallergenes Greer Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Laboratorios LETI
  • 2.7.1 Business Overview
  • 2.7.2 Subcutaneous Immunotherapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Laboratorios LETI Subcutaneous Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Subcutaneous Immunotherapy Market Competition, by Players

• 3.1 Global Subcutaneous Immunotherapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Subcutaneous Immunotherapy Players Market Share
  • 3.2.2 Top 10 Subcutaneous Immunotherapy Players Market Share
• 3.3 Market Competition Trend

4 Global Subcutaneous Immunotherapy Market Size by Regions

• 4.1 Global Subcutaneous Immunotherapy Revenue and Market Share by Regions
• 4.2 North America Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.5 South America Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

5 North America Subcutaneous Immunotherapy Revenue by Countries

• 5.1 North America Subcutaneous Immunotherapy Revenue by Countries (2014-2019)
• 5.2 USA Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

6 Europe Subcutaneous Immunotherapy Revenue by Countries

• 6.1 Europe Subcutaneous Immunotherapy Revenue by Countries (2014-2019)
• 6.2 Germany Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.3 UK Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.4 France Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Subcutaneous Immunotherapy Revenue by Countries

• 7.1 Asia-Pacific Subcutaneous Immunotherapy Revenue by Countries (2014-2019)
• 7.2 China Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.5 India Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

8 South America Subcutaneous Immunotherapy Revenue by Countries

• 8.1 South America Subcutaneous Immunotherapy Revenue by Countries (2014-2019)
• 8.2 Brazil Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Subcutaneous Immunotherapy by Countries

• 9.1 Middle East and Africa Subcutaneous Immunotherapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Subcutaneous Immunotherapy Revenue and Growth Rate (2014-2019)

10 Global Subcutaneous Immunotherapy Market Segment by Type

• 10.1 Global Subcutaneous Immunotherapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global Subcutaneous Immunotherapy Market Forecast by Type (2019-2024)
• 10.3 Asthma Revenue Growth Rate (2014-2024)
• 10.4 Allergic Rhinitis Revenue Growth Rate (2014-2024)
• 10.5 Venom Allergy Revenue Growth Rate (2014-2024)
• 10.6 Food Allergy Revenue Growth Rate (2014-2024)

11 Global Subcutaneous Immunotherapy Market Segment by Application

• 11.1 Global Subcutaneous Immunotherapy Revenue Market Share by Application (2014-2019)
• 11.2 Subcutaneous Immunotherapy Market Forecast by Application (2019-2024)
• 11.3 Hospital Pharmacies Revenue Growth (2014-2019)
• 11.4 Online Pharmacies Revenue Growth (2014-2019)
• 11.5 Retail Pharmacies Revenue Growth (2014-2019)

12 Global Subcutaneous Immunotherapy Market Size Forecast (2019-2024)

• 12.1 Global Subcutaneous Immunotherapy Market Size Forecast (2019-2024)
• 12.2 Global Subcutaneous Immunotherapy Market Forecast by Regions (2019-2024)
• 12.3 North America Subcutaneous Immunotherapy Revenue Market Forecast (2019-2024)
• 12.4 Europe Subcutaneous Immunotherapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Subcutaneous Immunotherapy Revenue Market Forecast (2019-2024)
• 12.6 South America Subcutaneous Immunotherapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Subcutaneous Immunotherapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology